Stevanato Group S P A 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 3.92, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Stevanato Group S P A in Dec 31 2025 quarter, has decreased to 93 days, compared to 99 days, in the 0 quarter.

If we take a look into Healthcare sector 511 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3505.

What is Receivable Turnover Ratio?
What is Stevanato Group S P A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STVN Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	2.28 %	2.28 %	2.28 %	2.28 %	-1.93 %
Y / Y Revenue Change	7.45 %	-	-	-	1.72 %
Receivable Turnover Ratio (TTM)	3.92	3.67	3.69	3.71	3.73
STVN's Total Ranking	# 3505	# 0	#	#	#
Accounts Receivable average collection period days	93	100	99	98	98
Seq. Receivable Change	0 %	0 %	0 %	2.28 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 165
Healthcare Sector	# 512
Overall Market	# 3505

Receivable Turnover Ratio Statistics
High	Average	Low
2.31	2.09	1.95
(Dec 31 2022)		(Dec 31 2023)

STVN Company Profile • Back to STVN Efficiency Comparisons • Compare STVN Receivables Turnover Ratio to its Competitors

Financial Statements
Stevanato Group S P A 's Accounts Receivable	$ 339 Millions	Visit STVN's Balance sheet
Stevanato Group S P A 's Sales TTM	$ 1,329 Millions	Visit STVN's Income Statement
Sources of STVN's Revenues		Visit STVN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STVN's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STVN's Growth Rates	STVN's Roa	STVN's Inventory Turnover Ratio	STVN's Dividend Comparisons
STVN's Profitability Ratios	STVN's Roi	STVN's Asset Turnover Ratio	STVN's Dividend Growth
STVN's Valuation Ratios	STVN's Roe	STVN's Financial Strength Ratios	STVN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Cue Biopharma Inc	10.70	$ 27.466 Millions	$ 2.566 Millions
Inventiva S a	10.68	$ 13.898 Millions	$ 1.301 Millions
Lifeloc Technologies Inc	10.58	$ 9.027 Millions	$ 0.853 Millions
Exact Sciences Corporation	10.49	$ 3,245.310 Millions	$ 309.460 Millions
Bioaffinity Technologies Inc	10.37	$ 6.162 Millions	$ 0.594 Millions
Bioxcel Therapeutics Inc	10.27	$ 0.642 Millions	$ 0.063 Millions
Utah Medical Products Inc	10.25	$ 38.001 Millions	$ 3.706 Millions
Addus Homecare Corp	10.15	$ 1,421.874 Millions	$ 140.113 Millions
Biolife Solutions Inc	10.11	$ 96.118 Millions	$ 9.506 Millions
Scisparc Ltd	10.07	$ 0.856 Millions	$ 0.085 Millions
Aquestive Therapeutics Inc	10.03	$ 44.545 Millions	$ 4.441 Millions
Viemed Healthcare Inc	9.97	$ 270.280 Millions	$ 27.120 Millions
Veracyte Inc	9.94	$ 489.532 Millions	$ 49.270 Millions
Zomedica Corp	9.93	$ 31.278 Millions	$ 3.150 Millions
Sanuwave Health Inc	9.92	$ 44.051 Millions	$ 4.439 Millions
Sunshine Biopharma Inc	9.91	$ 36.306 Millions	$ 3.662 Millions
Vireo Growth Inc.	9.89	$ 268.769 Millions	$ 27.182 Millions
Madrigal Pharmaceuticals Inc	9.87	$ 958.403 Millions	$ 97.105 Millions
International Stem Cell Corporation	9.86	$ 9.100 Millions	$ 0.923 Millions
Kestra Medical Technologies Ltd	9.85	$ 79.728 Millions	$ 8.092 Millions
Sol gel Technologies Ltd	9.85	$ 19.388 Millions	$ 1.968 Millions
Encompass Health Corporation	9.63	$ 5,935.200 Millions	$ 616.475 Millions
Biodesix Inc	9.62	$ 88.499 Millions	$ 9.200 Millions
Tandem Diabetes Care Inc	9.54	$ 1,011.039 Millions	$ 106.022 Millions
Prenetics Global Limited	9.51	$ 91.790 Millions	$ 9.656 Millions
Irhythm Holdings Inc	9.49	$ 746.250 Millions	$ 78.664 Millions
Septerna Inc	9.47	$ 45.951 Millions	$ 4.850 Millions
Pavmed Inc	9.47	$ 0.071 Millions	$ 0.008 Millions
Escalon Medical Corp	9.45	$ 12.311 Millions	$ 1.302 Millions
United Therapeutics Corporation	9.44	$ 3,182.700 Millions	$ 337.300 Millions

Date modified: 2026-07-07T13:27:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.